| Ascendis Pharma Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/12 |
07:30 |
| Immuneering Announces New Potentially Registrational Phase 2 Trial Evaluating Atebimetinib with Chemotherapy in Anaplastic Thyroid Cancer |
Globe Newswire |
11/12 |
07:30 |
| Dyadic’s C1-Produced RSV and Malaria Antibodies Advance into Animal Studies Following Positive Independent Evaluations |
Globe Newswire |
11/12 |
07:30 |
| Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials |
Globe Newswire |
11/12 |
07:30 |
| MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth |
Globe Newswire |
11/12 |
07:30 |
| Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/12 |
07:30 |
| Nexxen Reports Record Third Quarter 2026 Financial Results |
Globe Newswire |
11/12 |
07:30 |
| Immuneering to Collaborate with Astellas on Clinical Studies of Investigational CLDN18.2 Programs in Combination with Atebimetinib for Pancreatic Cancer Patients |
Globe Newswire |
11/12 |
07:30 |
| Bread Financial to Participate in the TD Cowen 2026 Financials & Fintech Conference |
Globe Newswire |
11/12 |
07:30 |
| Vor Bio Expands Strategic Partnership with RemeGen, Adding Next Generation, Long-Acting RC298 to BAFF/APRIL Franchise |
Globe Newswire |
11/12 |
07:30 |
| Quantum X Labs Joins the Global Race by Publishing Updated Execution Roadmap for Building its Cold-Atom Quantum Computer, Targeting Fault-Tolerant Computing by 2030 |
Globe Newswire |
11/12 |
07:25 |
| Generate Biomedicines Reports Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
07:20 |
| RCM Technologies, Inc. Announces Third Quarter 2026 Results |
Globe Newswire |
11/12 |
07:15 |
| The People Behind the Purpose: Colossal Recognized as a Top Workplace for Three Consecutive Years |
Globe Newswire |
11/12 |
07:11 |
| Lantronix and Latent AI Bring Persistent Target Tracking to Spotter for Group 1 UAS |
Globe Newswire |
11/12 |
07:05 |
| Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates |
Globe Newswire |
11/12 |
07:05 |
| JD.com Completes Voluntary Public Takeover Offer of CECONOMY |
Globe Newswire |
11/12 |
07:01 |
| Legence Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/12 |
07:00 |
| Parabilis Medicines Reports Third Quarter 2026 Financial Results and Provides Business Updates |
Globe Newswire |
11/12 |
07:00 |
| TScan Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/12 |
07:00 |
| Data I/O Reports Third Quarter 2026 Results |
Globe Newswire |
11/12 |
07:00 |
| Baker Hughes and TPAO Explore Industrializing Next-generation Geothermal in Türkiye for Always-on Power Generation |
Globe Newswire |
11/12 |
07:00 |
| Evidence Design Helps Launch the Samuel Oschin Air and Space Center |
Globe Newswire |
11/12 |
07:00 |
| Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
07:00 |
| YYForce (NASDAQ: YFOR) Secures 100+ Outlet Restaurant Staffing Deal Across Singapore |
Globe Newswire |
11/12 |
07:00 |